Details
-
Change Request
-
Resolution: Persuasive with Modification
-
Highest
-
FHIR Core (FHIR)
-
R4
-
Biomedical Research & Regulation
-
ClinicalUseDefinition (was ClinicalUseIssue)
-
-
Rik Smithies /Norman Gregory: 10-0-0
-
Correction
-
Non-compatible
-
Yes
-
R5
Description
Timing or duration of what? Timing or duration the activity should occur when associated with this indication? Duration the indication needs to exist to justify the use of the therapy? If the former, wouldn't this be tied to the full dosage - seems like that should live outside?
Proposed Wording:
lloyd@lmckenzie.com
(Comment 75 - imported by: Ron G. Parker)
Attachments
Issue Links
- is voted on by
-
BALLOT-16167 Negative - Ron G. Parker : 2021-May-FHIR R4B STU
- Closed